[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
Mani Foroohar Maintained (ARWR) at Hold with Increased Target to $33 on, Nov 10th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Mani Foroohar of SVB Leerink, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $32 to $33 on, Nov 10th, 2022.
Mani has made no other calls on ARWR in the last 4 months.
There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 1 agrees with Mani's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Galler of "Morgan Stanley" Initiated at Hold and Held Target at $41 on, Friday, September 9th, 2022
This is the rating of the analyst that currently disagrees with Mani
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $65 on, Monday, August 8th, 2022